Preclinical pharmacokinetic analysis of NOV-002, a glutathione disulfide mimetic - Wikidata - awgldk - TriplyDB

Preclinical pharmacokinetic analysis of NOV-002, a glutathione disulfide mimetic

Preclinical pharmacokinetic analysis of NOV-002, a glutathione disulfide mimetic

http://www.wikidata.org/entity/Q34065592

about

Preclinical pharmacokinetic analysis of armillarisin succinate ester in mouse plasma and tissues by LC-MS/MS.Cocaine-induced adaptations in cellular redox balance contributes to enduring behavioral plasticity.The glutathione disulfide mimetic NOV-002 inhibits cyclophosphamide-induced hematopoietic and immune suppression by reducing oxidative stress.The impact of redox and thiol status on the bone marrow: Pharmacological intervention strategies.Pharmacokinetic analysis and tissue distribution of andrographolide in rat by a validated LC-MS/MS method.Possible modulating impact of glutathione disulfide mimetic on physiological changes in irradiated rats.

P2860

Q34295227-3B2CE45E-CA49-4E6B-A965-E3FEC6AD3AE6 Q35356809-B0DDBF5B-350C-4FEF-89C7-D737FF26F0ED Q35925964-5C5168C9-55E2-48DB-AEAC-98F73C48FF5D Q37800633-7DE93D61-598F-49E6-8F4E-9E5A452F4504 Q47705243-7B74AC2B-85B5-446C-9B9E-6D987AE55401 Q50460640-BB4CC716-63AF-4CD1-AB0A-E36DB2162A4A

P2860

Preclinical pharmacokinetic analysis of NOV-002, a glutathione disulfide mimetic

http://www.wikidata.org/entity/Q34065592

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Preclinical pharmacokinetic analysis of NOV-002, a glutathione disulfide mimetic

@ast

Preclinical pharmacokinetic analysis of NOV-002, a glutathione disulfide mimetic

@en

Preclinical pharmacokinetic analysis of NOV-002, a glutathione disulfide mimetic

@nl

type

label

Preclinical pharmacokinetic analysis of NOV-002, a glutathione disulfide mimetic

@ast

Preclinical pharmacokinetic analysis of NOV-002, a glutathione disulfide mimetic

@en

Preclinical pharmacokinetic analysis of NOV-002, a glutathione disulfide mimetic

@nl

prefLabel

Preclinical pharmacokinetic analysis of NOV-002, a glutathione disulfide mimetic

@ast

Preclinical pharmacokinetic analysis of NOV-002, a glutathione disulfide mimetic

@en

Preclinical pharmacokinetic analysis of NOV-002, a glutathione disulfide mimetic

@nl

P1433

Q34065592-508660C8-51D9-4151-9125-A09FBD61AA7D

P1476

Q34065592-2744BCBA-90E6-45C1-BD0F-A65F522F9C02

P2093

Q34065592-0EA497A1-13B5-4046-9586-6B84DA821ABC

Q34065592-24A3D119-6754-4A4F-9506-5003F14195CB

Q34065592-697617D1-4043-477C-9FE7-FCDED63D8237

Q34065592-B350B0AF-058C-4CFB-BB80-6A3F901853F0

Q34065592-B8CD5C80-1176-4B6D-9594-64981397873B

Q34065592-CBBACBD3-99D0-41A1-8999-44A25A7DE267

Q34065592-DB5746D2-3D9D-4395-9615-A7A64C2C7964

Q34065592-E300F5A5-584A-4821-AAAF-5982E0DFCB3C

P2860

Q34065592-1776A5D0-B179-41B8-AD98-B9222F18824E

Q34065592-1BF27990-7EE4-46D9-BE65-EAAB9707996E

Q34065592-21E3EF84-B0BA-4BBE-AAEC-5B9FDB696584

Q34065592-2DBC4F66-DC7C-4322-ABBE-6A23BA977813

Q34065592-38630EE6-40E4-4DEB-81D3-B37B827B819B

Q34065592-508F20A4-EE91-4831-9BCC-9CF9980F05B2

Q34065592-6C892BE9-E319-45A0-8BF2-288F3A901479

Q34065592-6DF90C9B-FCA0-42A7-B770-33228868E77E

Q34065592-7053EE7A-0536-42A1-846A-635AB88F8180

Q34065592-7F63FD62-45CC-4BE9-AAC2-B4A4CF7B0A0D

P304

Q34065592-16E4CB71-FF00-43C8-9495-BDFABD765128

P31

Q34065592-36EF877F-CBD8-403F-99F4-70C5A4ABE3F9

P356

Q34065592-FACEFCEE-E786-4C74-8E03-D373197995D0

P433

Q34065592-8EC13BE3-6F99-417C-AE33-E97A0F2F85E9

P478

Q34065592-A4EFD711-CFD3-4F5D-BD4A-A38358675552

P577

Q34065592-0A8FB95C-C3AF-45D8-B7AF-65B5043CBBA0

P5875

Q34065592-8DF08F8E-2AE5-45FF-B95E-AC2CF9223E04

P698

Q34065592-959D975A-2674-4BB9-AC7F-1CF4CB833884

P932

Q34065592-9D0C874C-97BD-4641-BC01-F3B2FC40E28E

P356

J.BIOPHA.2010.01.003

P1433

Biomedicine and Pharmacotherapy

P1476

Preclinical pharmacokinetic analysis of NOV-002, a glutathione disulfide mimetic

@en

P2093

C J Pazoles

http://www.w3.org/2001/XMLSchema#string

D M Townsend

http://www.w3.org/2001/XMLSchema#string

J D Uys

http://www.w3.org/2001/XMLSchema#string

K D Tew

http://www.w3.org/2001/XMLSchema#string

L C Devane

http://www.w3.org/2001/XMLSchema#string

L He

http://www.w3.org/2001/XMLSchema#string

T E Garret

http://www.w3.org/2001/XMLSchema#string

Y Manevich

http://www.w3.org/2001/XMLSchema#string

P2860

Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple

Quantification of oxidative/nitrosative modification of CYS(34) in human serum albumin using a fluorescence-based SDS-PAGE assay.

Quantifying the global cellular thiol-disulfide status

Regulation of nuclear factor-kappa B, activator protein-1, and glutathione levels by tumor necrosis factor-alpha and dexamethasone in alveolar epithelial cells.

Comparing individual means in the analysis of variance.

Protective effects of a glutathione disulfide mimetic (NOV-002) against cisplatin induced kidney toxicity

NOV-002, a glutathione disulfide mimetic, as a modulator of cellular redox balance.

S-glutathionylation in protein redox regulation.

Novel role for glutathione S-transferase pi. Regulator of protein S-Glutathionylation following oxidative and nitrosative stress.

S-glutathionylation: indicator of cell stress and regulator of the unfolded protein response.

P304

493-498

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOPHA.2010.01.003

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42833086

http://www.w3.org/2001/XMLSchema#string

P698

20359856

http://www.w3.org/2001/XMLSchema#string

P932

2921589

http://www.w3.org/2001/XMLSchema#string